Home › NDC Lookup › RxCUI directory › RxCUI 978944

Dienogest 2 MG / estradiol valerate 2 MG Oral Tablet — RxCUI 978944

RxNorm drug concept · Semantic clinical drug
RxCUI 978944 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI978944
Official nameDienogest 2 MG / estradiol valerate 2 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped2
Package NDCs mapped5
Reported Medicaid activity (SDUD)4,257 prescriptions · 28 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Estradiol Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It's designed to ease the moderate to severe hot flashes and night sweats that come with menopause. When estrogen levels drop after menopause, your body's hormonal signals go a bit...
  • What exactly is this medication supposed to do for me?
  • Apply it to your upper thigh — alternating right and left sides each day — and spread it over an area roughly the size of two palm prints. Let it dry completely before getting dres...
  • How do I use the gel correctly so it actually works?
📖 Read our full Estradiol Topical guide →

🕸️ Concept Web — How Dienogest 2 MG / estradiol valerate 2 MG Oral Ta... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Dienogest 2 MG / estradiol valerate 2 MG Oral Tablet RxCUI 978944

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Dienogest 22968
    • Estradiol 4083
    • Dienogest / estradiol 994203
    • Estradiol valerate 24395
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Dienogest / estradiol Oral Tablet 978943
    • Dienogest / estradiol valerate Oral Tablet 2646918
    • Dienogest / estradiol Oral Product 1158329
    • Dienogest / estradiol Pill 1158330
    • Dienogest / estradiol valerate Oral Product 2660170
    • Dienogest / estradiol valerate Pill 2662832
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  3. Clinical & branded drugs 2

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Dienogest 2 MG 438962
    • Estradiol valerate 2 MG 978942
  4. Packs 2

    Fixed collections of drugs packaged and sold together, like dose packs.

Showing up to 8 concepts per family — 16 of 17 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

📦 FDA Products & Package NDCs

2 products · 5 package NDCs
5 package NDCs map to RxCUI 978944 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00781-4110-15 3 BLISTER PACK in 1 PACKAGE (0781-4110-15) / 1 KIT in 1 BLI... Estradiol Valerate and Estradiol Valerate/Dienogest Sandoz Inc 2020-01-21
50419-0409-00 90 BLISTER PACK in 1 PACKAGE (50419-409-00) / 1 KIT in 1 BL... Natazia Bayer HealthCare Pharmaceuticals Inc. 2010-05-06
50419-0409-03 3 BLISTER PACK in 1 PACKAGE (50419-409-03) / 1 KIT in 1 BLI... Natazia Bayer HealthCare Pharmaceuticals Inc. 2010-05-06
50419-0409-73 5 BLISTER PACK in 1 PACKAGE (50419-409-73) / 1 KIT in 1 BLI... Natazia Bayer HealthCare Pharmaceuticals Inc. 2010-05-06
50419-0409-76 2 BLISTER PACK in 1 PACKAGE (50419-409-76) / 1 KIT in 1 BLI... Natazia Bayer HealthCare Pharmaceuticals Inc. 2010-05-06
Observed labelers: Bayer HealthCare Pharmaceuticals Inc. (4) · Sandoz Inc (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.